• COVID-19 Testing at ResourcePath
    • COVID-19 Testing for Symptoms or Exposures
    • COVID-19 Testing for International Travel
    • COVID-19 Testing Customers
    • COVID-19 Testing Information for Physicians
  • Diffuse Midline Glioma Liquid Biopsy
    • H3K27M test information
  • Clinical Services
    • Slide Consultation
    • DICER1 Mutation Testing
    • Solid Tumor Mutation Testing
  • For Researchers
    • Digital Slide Scanning and Analysis
    • Gene Expression by Targeted RNA-Seq
  • Home
    • About
    • Staff
  • Contact Us
  • Customer Login
  • Customer Login
Resource Path
  • COVID-19 Testing at ResourcePath
    • COVID-19 Testing for Symptoms or Exposures
    • COVID-19 Testing for International Travel
    • COVID-19 Testing Customers
    • COVID-19 Testing Information for Physicians
  • Diffuse Midline Glioma Liquid Biopsy
    • H3K27M test information
  • Clinical Services
    • Slide Consultation
    • DICER1 Mutation Testing
    • Solid Tumor Mutation Testing
  • For Researchers
    • Digital Slide Scanning and Analysis
    • Gene Expression by Targeted RNA-Seq
  • Home
    • About
    • Staff
  • Contact Us

DICER1 Syndrome Research

Research section under development - coming soon!
DICER1 Germline and Tumor Testing International PPB Registry Research Pre-clinical and Clinical Trials International Ovarian and Testicular Stromal Tumor Registry For Patients and Families Donate
We are your research support company.

Contact us for a free consultation and quote.

Contact Us

Resourcepath, LLC
45945 Trefoil Lane. Suite 175
Sterling, VA 20166, USA

info@resourcepath.net
(571) 375-0755
  • Home
  • About
  • Staff
  • Pathology Core Lab
  • Clinical Services
  • DICER1 Mutation Testing
  • Diagnostics Pipeline
  • Contact Us
  • Website Privacy Policy
  • ©2021 ResourcePath.
  • All Rights Reserved.
  • Web Design by Perrill.